Bortezomib Treatment Produces Nocifensive Behavior and Changes in the Expression of TRPV1, CGRP, and Substance P in the Rat DRG, Spinal Cord, and Sciatic Nerve

Table 3

Percentage (±confidence limits) of TRPV1-, CGRP- and SP-LI DRG neurons in BTZ-treated rats.

Acute BTZ-treatment
	Ctrl	BTZ
TRPV1	26.86 ± 0.01%	29.55 ± 0.01%
CGRP	25.32 ± 0.01%	34.89 ± 0.01%
SP	15.86 ± 0.04%	14.73 ± 0.03%
Chronic BTZ-treatment
	Ctrl	BTZ
TRPV1	28.65 ± 0.02%	39.93 ± 0.03%
CGRP	28.59 ± 0.02%	34.87 ± 0.02%
SP	20.60 ± 0.01%	19.85 ± 0.01%